TISSIUM
CompanyFranceFounded 2022
TISSIUM develops one asset, in human trials (ECLIPSIUM System in atraumatic tissue reconstruction). Mostly device; based in France, founded in 2022.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 0
- Signals
Pipeline
1Biomorphic programmable polymer system for atraumatic tissue reconstruction.
Human trials, Device, atraumatic tissue reconstruction, tissue reconstruction
Full company profiles: pipeline, trials, funding and people.